Home
>
US Stocks
>
Kiniksa Pharmaceuticals Ltd - Class A
Kiniksa Pharmaceuticals Ltd - Class A
KNSA

Kiniksa Pharmaceuticals Ltd - Class A

$11.4410.06%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.6
Today Low/High
11.44 / 11.78
52 Week Low/High
$11.52 / $24.7
Market Cap
$402.62M

Company Details

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's portfolio of assets, ARCALYST, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases.
Organisation
Kiniksa Pharmaceuticals Ltd - Class A
Employees
168
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Kiniksa Pharmaceuticals Ltd - Class A share price today

Can Indians buy Kiniksa Pharmaceuticals Ltd - Class A shares?

How can I buy Kiniksa Pharmaceuticals Ltd - Class A shares from India?

Can Fractional shares of Kiniksa Pharmaceuticals Ltd - Class A be purchased?

What are the documents required to start investing in Kiniksa Pharmaceuticals Ltd - Class A stocks?

We are a SEBI registered investement advisor